Localization and function of KLF4 in cytoplasm of vascular smooth muscle cell

Biochemical and Biophysical Research Communications

Volumn 436, Issue 2, 2013, Pages 162-168

  Liu, Yan ^a,b   Zheng, Bin ^a   Zhang, Xin hua ^a   Nie, Chan juan ^a   Li, Yong hui ^a   Wen, Jin kun ^a  

^a The Key Laboratory of Neurobiology and Vascular Biology   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Actin; Cytoplasm; Cytoskeleton; KLF4; VSMC

Indexed keywords

ACTIN; EXPORTIN 1; KRUPPEL LIKE FACTOR 4; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RAT; SUMOYLATION; VASCULAR SMOOTH MUSCLE;

ACTIN CYTOSKELETON; ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; HEK293 CELLS; HUMANS; KARYOPHERINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SUMOYLATION;

EID: 84879603999     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.067     Document Type: Article

References (41)

1. Hutcheson R., Terry R., Chaplin J., Smith E., Musiyenko A., Russell J.C., Lincoln T., Rocic P. MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2013, 33:727-736.
2. Zemskov E.A., Mikhailenko I., Smith E.P., Belkin A.M. Tissue transglutaminase promotes PDGF/PDGFR-mediated signaling and responses in vascular smooth muscle cells. J. Cell. Physiol. 2012, 227:2089-2096.
3. Hedin U., Thyberg J., Roy J., Dumitrescu A., Tran P.K. Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 1997, 17:1977-1984.
4. Han M., Dong L.H., Zheng B., Shi J.H., Wen J.K., Cheng Y. Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundling. Life Sci. 2009, 84:394-401.
5. Doi H., Iso T., Yamazaki M., Akiyama H., Kanai H., Sato H., Kawai-Kowase K., Tanaka T., Maeno T., Okamoto E., Arai M., Kedes L., Kurabayashi M. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2328-2334.
6. Lagna G., Ku M.M., Nguyen P.H., Neuman N.A., Davis B.N., Hata A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J. Biol. Chem. 2007, 282:37244-37255.
7. Nakamura S., Hayashi K., Iwasaki K., Fujioka T., Egusa H., Yatani H., Sobue K. Nuclear import mechanism for myocardin family members and their correlation with vascular smooth muscle cell phenotype. J. Biol. Chem. 2010, 285:37314-37323.
8. Yang Y., Goldstein B.G., Chao H.H., Katz J.P. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther. 2005, 4:1216-1221.
9. Wu Z., Wang S. Role of kruppel-like transcription factors in adipogenesis. Dev. Biol. 2013, 373:235-243.
10. Zheng B., Han M., Wen J.K. Role of Kruppel-like factor 4 in phenotypic switching and proliferation of vascular smooth muscle cells. IUBMB Life 2010, 62:132-139.
11. Sun S.G., Zheng B., Han M., Fang X.M., Li H.X., Miao S.B., Su M., Han Y., Shi H.J., Wen J.K. MiR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep. 2011, 12:56-62.
12. Yu K., Zheng B., Han M., Wen J.K. ATRA activates and PDGF-BB represses the SM22alpha promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc. Res. 2011, 90:464-474.
13. Deaton R.A., Gan Q., Owens G.K. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1027-1037.
14. Zheng B., Han M., Bernier M., Zhang X.H., Meng F., Miao S.B., He M., Zhao X.M., Wen J.K. Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J. Biol. Chem. 2009, 284:22773-22785.
15. Zhang X.H., Zheng B., Gu C., Fu J.R., Wen J.K. TGF-beta1 downregulates AT1 receptor expression via PKC-delta-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-gamma association with KLF4. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1015-1023.
16. Zheng B., Han M., Shu Y.N., Li Y.J., Miao S.B., Zhang X.H., Shi H.J., Zhang T., Wen J.K. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARalpha acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res. 2011, 21:1487-1508.
17. Zheng B., Wen J.K., Han M. HhLIM is a novel F-actin binding protein involved in actin cytoskeleton remodeling. FEBS J. 2008, 275:1568-1578.
18. Shi J.H., Zheng B., Chen S., Ma G.Y., Wen J.K. Retinoic acid receptor alpha mediates all-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells. J. Biol. Chem. 2012, 287:10799-10811.
19. Zheng B., Han M., Wen J.K., Zhang R. Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2.5. Biochem. J. 2008, 409:683-690.
20. Yoshida T., Yamashita M., Hayashi M. Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells. J. Biol. Chem. 2012, 287:25706-25714.
21. Davis-Dusenbery B.N., Chan M.C., Reno K.E., Weisman A.S., Layne M.D., Lagna G., Hata A. Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J. Biol. Chem. 2011, 286:28097-28110.
22. Kee H.J., Kwon J.S., Shin S., Ahn Y., Jeong M.H., Kook H. Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4. Vascul. Pharmacol. 2011, 55:127-134.
23. Pandya A.Y., Talley L.I., Frost A.R., Fitzgerald T.J., Trivedi V., Chakravarthy M., Chhieng D.C., Grizzle W.E., Engler J.A., Krontiras H., Bland K.I., LoBuglio A.F., Lobo-Ruppert S.M., Ruppert J.M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 2004, 10:2709-2719.
24. Garvey S.M., Sinden D.S., Schoppee Bortz P.D., Wamhoff B.R. Cyclosporine up-regulates Kruppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo. J. Pharmacol. Exp. Ther. 2010, 333:34-42.
25. Inoue H., Kauffman M., Shacham S., Landesman Y., Yang J., Evans C.P., Weiss R.H. CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth. J. Urol. 2012, 189:2317-2326.
26. Stringham E.G., Marcus-Gueret N., Ramsay L., Schmidt K.L. Live cell imaging of the cytoskeleton. Methods Enzymol. 2012, 505:203-217.
27. Miano J.M., Long X., Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 2007, 292:C70-81.
28. Miano J.M. Role of serum response factor in the pathogenesis of disease. Lab. Invest. 2010, 90:1274-1284.
29. Ly D.L., Waheed F., Lodyga M., Speight P., Masszi A., Nakano H., Hersom M., Pedersen S.F., Szaszi K., Kapus A. Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton. Am. J. Physiol. Cell Physiol. 2013, 304:C115-127.
30. Morita T., Mayanagi T., Sobue K. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs). Exp. Cell Res. 2007, 313:3432-3445.
31. Morita T., Mayanagi T., Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell Biol. 2007, 179:1027-1042.
32. Meng F., Han M., Zheng B., Wang C., Zhang R., Zhang X.H., Wen J.K. All-trans retinoic acid increases KLF4 acetylation by inducing HDAC2 phosphorylation and its dissociation from KLF4 in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2009, 387:13-18.
33. Salmon M., Gomez D., Greene E., Shankman L., Owens G.K. Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22alpha promoter mediates transcriptional silencing during SMC phenotypic switching in vivo. Circ. Res. 2012, 111:685-696.
34. Evans P.M., Zhang W., Chen X., Yang J., Bhakat K.K., Liu C. Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem. 2007, 282:33994-34002.
35. Tahmasebi S., Ghorbani M., Savage P., Yan K., Gocevski G., Xiao L., You L., Yang X.J. Sumoylation of Kruppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation. J. Biol. Chem. 2013, 288:12791-12804.
36. Kawai-Kowase K., Ohshima T., Matsui H., Tanaka T., Shimizu T., Iso T., Arai M., Owens G.K., Kurabayashi M. PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler. Thromb. Vasc. Biol. 2009, 29:99-106.
37. Liu Y., Sinha S., McDonald O.G., Shang Y., Hoofnagle M.H., Owens G.K. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 2005, 280:9719-9727.
38. Kim J.H., Nam S.W., Kim B.W., Kim W.J., Choi Y.H. Astaxanthin improves the proliferative capacity as well as the osteogenic and adipogenic differentiation potential in neural stem cells. Food Chem. Toxicol. 2010, 48:1741-1745.
39. King K.E., Iyemere V.P., Weissberg P.L., Shanahan C.M. Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J. Biol. Chem. 2003, 278:11661-11669.
40. Wassmann S., Wassmann K., Jung A., Velten M., Knuefermann P., Petoumenos V., Becher U., Werner C., Mueller C., Nickenig G. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2007, 43:301-307.
41. Schuetz A., Nana D., Rose C., Zocher G., Milanovic M., Koenigsmann J., Blasig R., Heinemann U., Carstanjen D. The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation. Cell. Mol. Life Sci. 2011, 68:3121-3131.